GSDMD

Gasdermin-D · P57764 · GSDMD on Sugi Atlas →

1,235 patent compounds predicted against GSDMD, 640 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
Disulfiram Disulfiram (SCHEMBL27213) 1.00 2/20
Disulfiram Disulfiram (SCHEMBL4654748) 1.00 2/20
Disulfiram Disulfiram (SCHEMBL5364281) 0.94 2/20
Disulfiram Disulfiram (SCHEMBL5961375) 0.94 2/20
Disulfiram Disulfiram (SCHEMBL10886601) 0.94 2/20
Disulfiram Disulfiram (SCHEMBL11155542) 0.94 2/20
Disulfiram Disulfiram (SCHEMBL28074264) 0.94 2/20
Disulfiram Disulfiram (SCHEMBL28246322) 0.94 2/20
Disulfiram Disulfiram (SCHEMBL28867973) 0.94 2/20
Ditiocarb Ditiocarb (SCHEMBL80288) 0.94 2/20
Ditiocarb Ditiocarb (SCHEMBL81092) 0.94 2/20
Ditiocarb Ditiocarb (SCHEMBL452142) 0.94 2/20
Ditiocarb Ditiocarb (SCHEMBL1395953) 0.94 2/20
Ditiocarb Ditiocarb (SCHEMBL2234902) 0.94 2/20
Ditiocarb Ditiocarb (SCHEMBL9700626) 0.94 2/20
Ditiocarb Ditiocarb (SCHEMBL21359739) 0.94 2/20
Ditiocarb Ditiocarb (SCHEMBL25284941) 0.94 2/20
Ditiocarb Ditiocarb (SCHEMBL28803715) 0.94 2/20
Disulfiram Disulfiram (SCHEMBL4734237) 0.89 2/20
Disulfiram Disulfiram (SCHEMBL10542872) 0.89 2/20

Clinical trials — most relevant to GSDMD by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Disulfiram in Rheumatoid Arthritis PHASE2NOT_YET_RECRUITING
Efficacy and Safety of Empagliflozin in GSD-Ib Patients PHASE2WITHDRAWN
Evaluation of Serum Gasdermin D Level As a Potential Biomarker of Disease Activity in Vitiligo Patients nanUNKNOWN
New Signaling Pathway Targeting Systemic Lupus Erythematosus nanUNKNOWN
The Role of Pyroptosis in Chronic Venous Disease nanUNKNOWN
Effect of Periodontal Treatment on Inflammasome Proteins in Periodontal Diseases nanUNKNOWN
Early Diagnosis and Prognosis of Postoperative Sepsis by Presepsin and Syndecan-1 nanUNKNOWN
Inflammasomes in Cell Death in FTMH, ERM, and RRD nanCOMPLETED
Role of Type 2 Diabetes in Potentiating the Inflammatory Response Post Extracorporeal Circulation After Cardiac Surgery nanWITHDRAWN
Caspase-1 Activity, IL-1beta, and IL-18 in Patients With FMF nanNOT_YET_RECRUITING
Probiotics and Systemic Inflammation in Patients With Metabolic Syndrome and High Cardiovascular Risk nanWITHDRAWN
Gluten-related Disorders in Familial Mediterranean Fever Patients nanCOMPLETED
The T Cell Activator of Cell Killing (TACK) IT ON STUDY nanRECRUITING
The Mechanisms and Significances of Synergistic Effects of Mycophenolic Acid and LPS on IL-1β Secretion by Mononuclear nanUNKNOWN
Evaluation of Inflammasome Gene Polymorphisms in Periodontitis Patients nanUNKNOWN
Decoding the Genetic Landscape of Skeletal Diseases nanRECRUITING
Extremes of Coronary Artery Disease and Normality:CAD Extremes nanRECRUITING
Genome Analysis of Human Endogenous Retroviruses (HERVs)(COVID19) nanRECRUITING
Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still'S-like Diseases, and Other Undifferentiated Autoinflammatory Diseases) nanRECRUITING
Activation of a Cutaneous Inflammasome in the Skin of Hidradenitis Suppurativa Patients nanCOMPLETED
Characterization of Non-canonical Way in Inflammasome Monocytes of Patients With Severe Sepsis nanCOMPLETED
RNA Cloning and Visualization in Human Atherosclerosis nanCOMPLETED
Macrolide Mediates Pulmonary Infection of Pseudomonas Aeruginosa nanCOMPLETED
Pathogenic Mechanisms in C Diff Infection and Colitis nanCOMPLETED
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry Bad Cholesterol in the Blood nanCOMPLETED
Kinetics of Nasal Cytokine Responses to Mechanical Stimulation nanCOMPLETED
Predicting Pancreatic Necrosis Using mitDNA nanUNKNOWN
Biomarker for Glycogen Storage Diseases (BioGlycogen) nanWITHDRAWN
Role NLRP3 Inflammasome in Weight Loss Following Sleeve Gastrectomy in Morbidly Obese Patients nanUNKNOWN
Apoptosis Markers in Aggressive Periodontitis nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a GSDMD binder may also engage these)

ProteinNameSimilarity
Q9D8T2 0.997 Q9D8T2 →
Q8CB12 0.990 Q8CB12 →
P85967 0.990 P85967 →
Q96QA5 0.990 Q96QA5 →
Q5Y4Y6 0.989 Q5Y4Y6 →
Q99NB5 0.988 Q99NB5 →
Q32M21 0.988 Q32M21 →
Q9BYG8 0.986 Q9BYG8 →
Q3TR54 0.986 Q3TR54 →
Q9EST1 0.985 Q9EST1 →
Q2KHK6 0.984 Q2KHK6 →
Q6PDZ2 0.983 Q6PDZ2 →
Q8TAX9 0.981 Q8TAX9 →
Q80VA5 0.981 Q80VA5 →
Q8CIE4 0.980 Q8CIE4 →
Q15572 0.980 Q15572 →
Q8K330 0.978 Q8K330 →
A1L3T7 0.978 A1L3T7 →
Q9EQR6 0.978 Q9EQR6 →
A0A8I3PMN2 0.978 A0A8I3PMN2 →
Q8CFK6 0.977 Q8CFK6 →
P70434 0.977 P70434 →
Q8BHW9 0.977 Q8BHW9 →
P33076 0.977 P33076 →
Q5PNP6 0.977 Q5PNP6 →
Q5EE38 0.977 Q5EE38 →
Q9HB65 0.976 Q9HB65 →
Q5T124 0.976 Q5T124 →
Q8BLY7 0.976 Q8BLY7 →
Q3U0V2 0.976 Q3U0V2 →